Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.87
+0.33 (1.24%)
Nov 22, 2024, 4:00 PM EST - Market closed
Immunovant Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Immunovant stock have an average target of 48.1, with a low estimate of 36 and a high estimate of 55. The average target predicts an increase of 79.01% from the current stock price of 26.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunovant stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 8 | 6 | 6 | 6 |
| Buy | 7 | 7 | 7 | 5 | 6 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 15 | 11 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +89.80% | Nov 8, 2024 |
| Raymond James | Raymond James | Buy Initiates $36 | Buy | Initiates | $36 | +33.98% | Oct 10, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $47 → $53 | Buy | Maintains | $47 → $53 | +97.25% | Oct 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +89.80% | Sep 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +89.80% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
11.52M
EPS This Year
-2.63
from -1.88
EPS Next Year
-2.85
from -2.63
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 103.6M | 616.7M | ||
| Avg | n/a | 11.5M | 123.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 5,254.5% | ||
| Avg | - | - | 972.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.98 | -2.06 | 0.01 | ||
| Avg | -2.63 | -2.85 | -2.35 | ||
| Low | -2.91 | -3.20 | -3.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.